The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors
The specific application of photobiomodulation to the GLP-1 patient population as a concurrent adjunct during active medication-facilitated weight loss is a reasoned clinical extension of these mechanisms
The recommended injection sites include the abdomen, thigh, and upper arm, rotating them with each dose to prevent pain, bruising, and skin thickening
Also, our formula includes Akkermansia, one of the most powerful natural GLP-1 boosters available
Maintenance is most successful when it is treated as an active phase of care, not as the end of treatment
Maintenance Phase Many individuals who have achieved their weight loss goals opt to continue GLP-1 medications in a maintenance phase